Lafayette Investments, Inc. Gsk PLC Transaction History

Lafayette Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	BUY	$36.52 - $41.46 $31,188 - $35,406	854 Added 3.02%	29,104 $1.16 Million
Q3 2020 Oct 30, 2020	SELL	$38.11 - $42.99 $15,244 - $17,196	-400 Reduced 1.4%	28,250 $1.06 Million
Q2 2019 Aug 12, 2019	SELL	$39.4 - $42.7 $1.13 Million - $1.22 Million	-28,650 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$37.8 - $42.69 $53,940 - $60,918	-1,427 Reduced 4.74%	28,650 $1.1 Million
Q3 2018 Nov 08, 2018	BUY	$39.75 - $42.69 $50,164 - $53,874	1,262 Added 4.38%	30,077 $1.21 Million
Q1 2018 May 15, 2018	SELL	$36.18 - $40.15 $289,440 - $321,200	-8,000 Reduced 21.73%	28,815 $1.13 Million
Q2 2017 Aug 14, 2017	BUY	N/A	36,815	36,815 $1.59 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Lafayette Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Lafayette Investments, Inc. with notifications on news.